Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice
2008
Gene Expression in Pancreatic Cancer in Mice
publication
Evidence: moderate
Author Information
Author(s): Thakur Archana, Bollig Aliccia, Wu Jiusheng, Liao Dezhong J
Primary Institution: Karmanos Cancer Institute, Wayne State University School of Medicine
Hypothesis
Identifying gene expression profiles in pancreatic tumors and metastatic lesions may reveal biomarkers for cancer progression.
Conclusion
The study identified Igfbp1 and Serpina1 as potential biomarkers for metastatic pancreatic cancer.
Supporting Evidence
- The study found that genes involved in RNA processing were upregulated in both primary tumors and metastatic lesions.
- Igfbp1 and Serpina1 showed high expression in liver metastatic lesions but low in primary tumors.
- The research utilized Ela-c-myc transgenic mice to model pancreatic cancer.
Takeaway
Researchers looked at genes in pancreatic cancer in mice to find clues about how the disease spreads and what might help treat it.
Methodology
Gene expression was analyzed using cDNA microarray and confirmed with RT-PCR.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website